Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Capital/Financing Update 2009

Apr 21, 2009

65122_rns_2009-04-21_fc48c3f7-d0aa-4138-8f8e-dd81a09a616c.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [193 x 52] intentionally omitted <==

ASX ANNOUNCEMENT

Replacement Notice Under Section 708A(5) of the Corporations Act [ASX Code: PRR]

Wednesday 22[nd] April 2009

This replaces the Section 708A notice lodged on Tuesday, 21[st] April 2009

This notice is given under paragraph (5)(e) of section 708A of the Corporations Act.

The Following securities of the Company were issued for services rendered without disclosure to investors under Part 6D.2 of the Corporations Act:

Type: OrdinaryShares
Class/Description: Ordinary (Fully Paid)
ASX Code: PRR
Date of Issue: 21stof April 2009
Number Issued: 5,473,684
Issue Priceper Security: $0.019

The Company intends to apply to Australian Stock Exchange Limited for quotation of the above shares.

As at the date of this notice, the Company has complied with:

a) The provisions of Chapter 2M of the Corporations Act as they apply to the Company; and b) Section 674 of the Corporations Act.

Other information which is excludedinformation required to be disclosed underparagraph 708A (7) & 708A(8) of theCorporationsAct None

For and on behalf of the Company,

==> picture [139 x 42] intentionally omitted <==

Robert Kleine Company Secretary Prima Biomed Limited